Objective: Axillary lymph node dissection(ALND) may be unnecessary in 20%–60% of breast cancer patients with sentinel lymph node(NSLN) metastasis. The aim of the present study was to review the medical records of Chi...Objective: Axillary lymph node dissection(ALND) may be unnecessary in 20%–60% of breast cancer patients with sentinel lymph node(NSLN) metastasis. The aim of the present study was to review the medical records of Chinese patients with early-stage breast cancer and positive NSLN metastasis to identify clinicopathological characteristics as risk factors for non-NSLN metastasis.Methods: The medical records of 2008 early-stage breast cancer patients who received intraoperative sentinel lymph node biopsy(SLNB) between 2006 and 2016 were retrospectively reviewed. These patients were clinically and radiologically lymph nodenegative and had no prior history of receiving neoadjuvant chemotherapy or endocrinotherapy. The clinicopathological characteristics of patients with positive NSLN metastasis who underwent ALND were investigated.Results: In the present study, 296 patients with positive NSLN metastases underwent ALND. Positive non-NSLN metastases were confirmed in 95 patients(32.1%). On univariate analysis, ≥ 3 positive NSLN metastases(P <0.01), NSLN macrometastases(P =0.023), and lymphovascular invasion(P = 0.04) were associated with non-NSLN metastasis(P <0.05). In multivariate analysis, the number of positive SLNs was the most significant predictor of non-SLN metastasis. For patients with 0, 1, 2, or 3 associated risk factors, the non-SLN metastatic rates were 11.5%, 22.5%, 35.2%, and 73.1%, respectively.Conclusions: The number of positive NSLNs, NSLN macrometastases, and lymphovascular invasion were correlated with nonSLN metastasis. The number of positive SLNs was an independent predictor for non-NSLN metastasis. When 2 or 3 risk factors were present in one patient, the probability of non-NSLN was higher than that in the American College of Surgeons Oncology Group Z0011 trial(27.3%); thus, avoiding ALND should be considered carefully.展开更多
Background:Sentinel lymph node(SLN)biopsy is gradually accepted as the standard of care in breast cancer patients with down-staged axillary disease after neoadjuvant chemotherapy(NAC).However,it is still difficult to ...Background:Sentinel lymph node(SLN)biopsy is gradually accepted as the standard of care in breast cancer patients with down-staged axillary disease after neoadjuvant chemotherapy(NAC).However,it is still difficult to precisely define pre-NAC clinical node-positive(cN1)and post-NAC clinical node-negative(ycN0).This prospective single-center trial was designed to evaluate the feasibility and accuracy of standard targeted axillary dissection(TAD)after NAC in highly selective pre-NAC cN1 patients(not considering ultrasound-based axillary ycN staging).Methods:This prospective trial included patients with initial pre-NAC cT1-3N1M0 invasive breast cancer but with a rigorous definition of cN1 from the Affiliated Cancer Hospital of Zhengzhou University.When NAC was effective(including complete and partial responses)and preoperative axillary palpation was negative,preoperative ultrasound-based axillary staging was not considered,and all patients underwent TAD followed by axillary lymph node(LN)dissection.The detection rate(DR)and false-negative rate(FNR)of TAD were calculated.Results:A total of 82 patients were included,and 77 of them were eligible for data analysis.The DR for TAD was 94.8%(73/77).There were 26 patients with one abnormal LN at the time of diagnosis based on ultrasound,45 patients with two,and 2 patients with three.One patient had one TAD LN,four patients had two TAD LNs,and 68 patients had three or more TAD LNs.Preoperative axillary palpation yielded negative results for all 73 patients who successfully underwent TAD.Preoperative ultrasound-based ycN0 and ycN+conditions were detected for 52 and 21 cases,respectively.The FNR was 7.4%(2/27)for standard TAD(≥3 SLNs),which was lower than that of all successful TAD(≥1 SLN;10.0%,3/30).Conclusions:In rigorously defined pre-NAC cN1 breast cancer patients,standard TAD is feasible for those with negative axillary palpation after NAC,and FNR is also less than 10%.Registration:chictr.org.cn,ChiCTR2100049093.展开更多
BACKGROUND Occult breast cancer(OBC)has traditionally been considered to be a carcinoma of unknown primary origin with a favorable prognosis and can be treated as stage II-III breast cancer.Due to the small number of ...BACKGROUND Occult breast cancer(OBC)has traditionally been considered to be a carcinoma of unknown primary origin with a favorable prognosis and can be treated as stage II-III breast cancer.Due to the small number of cases and limited clinical experience,treatments vary greatly around the world and no standardized treatment has yet been established.AIM To investigate the clinicopathological features,psychological status and prognostic features of patients with OBC.METHODS The clinicopathological data of 33 OBC patients diagnosed and treated in the Affiliated Hospital of Xuzhou Medical University and Xuzhou Central Hospital from November 2015 to November 2022 were retrospectively analyzed.The psychological status of OBC patients was evaluated by the Self-rating Anxiety Scale and Self-rating Depression Scale.Patients’emotions,stress perception and psychological resilience were evaluated by the Positive and Negative Affect Schedule,the Chinese Perceived Stress Scale,and the Connor-Davidson Resilience Scale(CD-RISC),respectively.Patient survival was calculated using the Kaplan-Meier method,and survival curves were plotted for analysis with the log-rank test.Univariate and multivariate survival analyses were performed using the Cox regression model.RESULTS The 33 OBC patients included 32 females and 1 male.Of the 33 patients,30(91%)had axillary tumors,3(9%)had a neck mass as the primary symptom;18(54.5%)had estrogen receptor-positive tumors,17(51.5%)had progesterone receptor-positive tumors,and 18(54.5%)had Her-2-positive tumors;24(72.7%)received surgical treatment,including 18 patients who underwent modified radical mastectomy,1 patient who underwent breast-conserving surgery plus axillary lymph node dissection(ALND),and 5 patients who underwent ALND alone;12 patients received preoperative neoadjuvant therapy.All 30 patients developed anxiety and depression,with low positive affect scores and high negative affect scores,accompanied by a high stress level and poor psychological resilience.There were no differences i展开更多
Objective: To compare the efficacy of axillary radiotherapy (ART) with that of completion axillary lymph node dissection (cALND) in clinically node-negative breast cancer patients with a positive sentinel lymph node. ...Objective: To compare the efficacy of axillary radiotherapy (ART) with that of completion axillary lymph node dissection (cALND) in clinically node-negative breast cancer patients with a positive sentinel lymph node. Methods: A literature search was performed in PubMed, EMBASE and Cochrane Library by using the search terms 'breast cancer', 'sentinel lymph node biopsy', 'axillary radiotherapy' or 'regional node irradiation' for articles published between 2004 and 2016. Only randomized controlled trials that included patients with positive sentinel nodes were included in the meta-analysis. Results: Two randomized controlled trials and three retrospective studies were identified. The reported overall survival rate (hazard ratio [HR] = 1.09, 95% confidence interval [CI]: 0.75-1.43, P = 0.365), disease-free survival rate (HR = 1.01, 95% CI:0.58-1.45, P = 0.144), and axillary recurrence rate (1.2% and 0.4%, and 1.3% and 0.8%, respectively) were similar in both groups. The absence of knowledge on the extent of nodal involvement in the ART group appeared to have no major impact on the administration of adjuvant systemic therapy. Conclusions: ART is not inferior to cALND in the patients with clinically node-negative breast cancer who had a positive sentinel lymph node. Information obtained by using cALND after SLNB may have no major impact on the administration of adjuvant systemic therapy.展开更多
目的：探讨在乳腺癌腋窝淋巴结清扫术中超声刀和普通电刀对乳腺癌术后并发症的影响。方法回顾性分析92例乳腺癌腋窝淋巴结清扫术患者的临床资料，患者随机选择手术方式，其中采用超声刀37例，普通电刀55例，比较两组患者淋巴结检出数、...目的：探讨在乳腺癌腋窝淋巴结清扫术中超声刀和普通电刀对乳腺癌术后并发症的影响。方法回顾性分析92例乳腺癌腋窝淋巴结清扫术患者的临床资料，患者随机选择手术方式，其中采用超声刀37例，普通电刀55例，比较两组患者淋巴结检出数、手术时间、术后24 h 引流量、血清肿发生率和腋窝引流管留置时间。结果超声刀组手术时间为（148．2±30．4）min、检出淋巴结17个，腋窝引流管留置时间为（16．0±5．3）d，普通电刀组分别为（143．5±40．8）min，16个和（16．7±4．4），两组比较差异无统计学意义（P ＞0．05），超声刀组术后24 h 引流量为（118．8±65．8）ml，血清肿发生率为8．1％；普通电刀组分别为（159．2±71．3）ml 和20％，两组比较差异有统计学意义（P ＜0．01）。结论在乳腺癌腋窝淋巴结清扫术中超声刀和普通电刀对腋窝淋巴结清扫效果比较无明显差异，但采用超声刀后患者术后并发症明显减少。展开更多
The sentinel lymph node biopsy(SLNB) was initially pioneered for staging melanoma in 1994 and it has been subsequently validated by several trials, and has become the new standard of care for patients with clinically ...The sentinel lymph node biopsy(SLNB) was initially pioneered for staging melanoma in 1994 and it has been subsequently validated by several trials, and has become the new standard of care for patients with clinically node negative invasive breast cancer. The focussed examination of fewer lymph nodes in addition to improvements in histopathological and molecular analysis has increased the rate at which micrometastases and isolated tumour cells are identified. In this article we review the literature regarding the optimal management of the axilla when the SLNB is positive for metastatic disease based on level 1 evidence derived from randomised clinical trials.展开更多
目的研究保留上肢淋巴结的乳腺癌腋窝淋巴结清扫术对预防上肢淋巴水肿的影响。方法方便选择2014年1月—2015年6月期间该院收治的T1~3 No Mo期70例乳腺癌患者,依照数字法随机分成观察组（35例）和对照组（35例）。分别为术前以纳米炭混...目的研究保留上肢淋巴结的乳腺癌腋窝淋巴结清扫术对预防上肢淋巴水肿的影响。方法方便选择2014年1月—2015年6月期间该院收治的T1~3 No Mo期70例乳腺癌患者,依照数字法随机分成观察组（35例）和对照组（35例）。分别为术前以纳米炭混悬液行经上臂逆行腋窝淋巴结示踪术组（观察组）和行经典腋窝淋巴结清扫术的对照组,比较两组疗效和预后。结果观察组术后1、4周及6个月患侧比健侧上肢臂围增加的百分比为（1.8±0.8）%、（1.8±0.7）%、（1.0±0.3）%,较对照组的（4.7±1.2）%、（4.5±1.1）%、（3.0±0.8）%减少更加明显（P〈0.05）。观察组术后预防上肢淋巴水肿的效果的优良率为97.14%（34/35）,明显高于对照组的71.43%（25/35）（P〈0.05）。观察组对于上肢淋巴水肿预防情况评分由（63.2±11.4）分改善至（87.3±10.3）分,明显高于对照组（P〈0.05）,差异均有统计学意义。结论保留上肢淋巴结的乳腺癌腋窝淋巴结清扫术对预防上肢淋巴水肿效果较好,值得推荐。展开更多
The intercostobrachial nerve (ICBN) is responsible for the sensory</span></span></span></span></span><span><span><span><span><span><span style="font-...The intercostobrachial nerve (ICBN) is responsible for the sensory</span></span></span></span></span><span><span><span><span><span><span style="font-family:""><span style="font-family:Verdana;"> innervation of a part of the inner side of the arm. Injury of the intercostobrachial nerve is </span><span style="font-family:Verdana;">a complication of axillary dissection during lymph node dissection.</span> <b><span style="font-family:Verdana;">Objective</span></b><span style="font-family:Verdana;">: </span><span style="font-family:Verdana;">This study aimed to determine the effect of preservation of the</span><span style="font-family:Verdana;"> intercostobra</span><span><span style="font-family:Verdana;">chial nerve on postoperative sensory disturbances. </span><b><span style="font-family:Verdana;">Methods:</span></b><span style="font-family:Verdana;"> This is a</span></span><span style="font-family:Verdana;"> prospective, single-center study which was carried out in 90 patients followed in the oncology department of the Aristide Le Dantec hospital in Dakar, suffering </span><span style="font-family:Verdana;">from breast cancer and having undergone breast surgery associated with</span><span style="font-family:Verdana;"> axillary </span><span style="font-family:Verdana;">dissection, for a period of 6 months. The patients were divided into two</span><span style="font-family:Verdana;"> groups depending on whether the intercostobrachial nerve (ICBN) was preserved or </span><span style="font-family:Verdana;">not. The two groups were compared in terms of the incidence of sensory</span><span style="font-family:Verdana;"> disturbances. </span><b><span style="font-family:Verdana;">Results:</span></b><span style="font-family:Verdana;"> Sixty patients without nerve preservation and 30 patients with nerve preservation were included in the study, </span><i><span style="font-family:Verdana;">i.e.</span></i><span style="font-family:Verdana;">, 90 patients in total. </span><span style="font-family:Verdana;">ICBN was injured in 60 pa展开更多
文摘Objective: Axillary lymph node dissection(ALND) may be unnecessary in 20%–60% of breast cancer patients with sentinel lymph node(NSLN) metastasis. The aim of the present study was to review the medical records of Chinese patients with early-stage breast cancer and positive NSLN metastasis to identify clinicopathological characteristics as risk factors for non-NSLN metastasis.Methods: The medical records of 2008 early-stage breast cancer patients who received intraoperative sentinel lymph node biopsy(SLNB) between 2006 and 2016 were retrospectively reviewed. These patients were clinically and radiologically lymph nodenegative and had no prior history of receiving neoadjuvant chemotherapy or endocrinotherapy. The clinicopathological characteristics of patients with positive NSLN metastasis who underwent ALND were investigated.Results: In the present study, 296 patients with positive NSLN metastases underwent ALND. Positive non-NSLN metastases were confirmed in 95 patients(32.1%). On univariate analysis, ≥ 3 positive NSLN metastases(P <0.01), NSLN macrometastases(P =0.023), and lymphovascular invasion(P = 0.04) were associated with non-NSLN metastasis(P <0.05). In multivariate analysis, the number of positive SLNs was the most significant predictor of non-SLN metastasis. For patients with 0, 1, 2, or 3 associated risk factors, the non-SLN metastatic rates were 11.5%, 22.5%, 35.2%, and 73.1%, respectively.Conclusions: The number of positive NSLNs, NSLN macrometastases, and lymphovascular invasion were correlated with nonSLN metastasis. The number of positive SLNs was an independent predictor for non-NSLN metastasis. When 2 or 3 risk factors were present in one patient, the probability of non-NSLN was higher than that in the American College of Surgeons Oncology Group Z0011 trial(27.3%); thus, avoiding ALND should be considered carefully.
基金supported by a grant from the Science and Technology development plan of Henan(No.202102310428)
文摘Background:Sentinel lymph node(SLN)biopsy is gradually accepted as the standard of care in breast cancer patients with down-staged axillary disease after neoadjuvant chemotherapy(NAC).However,it is still difficult to precisely define pre-NAC clinical node-positive(cN1)and post-NAC clinical node-negative(ycN0).This prospective single-center trial was designed to evaluate the feasibility and accuracy of standard targeted axillary dissection(TAD)after NAC in highly selective pre-NAC cN1 patients(not considering ultrasound-based axillary ycN staging).Methods:This prospective trial included patients with initial pre-NAC cT1-3N1M0 invasive breast cancer but with a rigorous definition of cN1 from the Affiliated Cancer Hospital of Zhengzhou University.When NAC was effective(including complete and partial responses)and preoperative axillary palpation was negative,preoperative ultrasound-based axillary staging was not considered,and all patients underwent TAD followed by axillary lymph node(LN)dissection.The detection rate(DR)and false-negative rate(FNR)of TAD were calculated.Results:A total of 82 patients were included,and 77 of them were eligible for data analysis.The DR for TAD was 94.8%(73/77).There were 26 patients with one abnormal LN at the time of diagnosis based on ultrasound,45 patients with two,and 2 patients with three.One patient had one TAD LN,four patients had two TAD LNs,and 68 patients had three or more TAD LNs.Preoperative axillary palpation yielded negative results for all 73 patients who successfully underwent TAD.Preoperative ultrasound-based ycN0 and ycN+conditions were detected for 52 and 21 cases,respectively.The FNR was 7.4%(2/27)for standard TAD(≥3 SLNs),which was lower than that of all successful TAD(≥1 SLN;10.0%,3/30).Conclusions:In rigorously defined pre-NAC cN1 breast cancer patients,standard TAD is feasible for those with negative axillary palpation after NAC,and FNR is also less than 10%.Registration:chictr.org.cn,ChiCTR2100049093.
基金Supported by Jiangsu Provincial Health Commission’s 2020 High-Level Health Talents“Six Ones Project”Top-Notch Talent Research Project,No.LGY20200062021 Youth Medical Science Innovation Project of Xuzhou Health Commission,No.XWKYHT20210580.
文摘BACKGROUND Occult breast cancer(OBC)has traditionally been considered to be a carcinoma of unknown primary origin with a favorable prognosis and can be treated as stage II-III breast cancer.Due to the small number of cases and limited clinical experience,treatments vary greatly around the world and no standardized treatment has yet been established.AIM To investigate the clinicopathological features,psychological status and prognostic features of patients with OBC.METHODS The clinicopathological data of 33 OBC patients diagnosed and treated in the Affiliated Hospital of Xuzhou Medical University and Xuzhou Central Hospital from November 2015 to November 2022 were retrospectively analyzed.The psychological status of OBC patients was evaluated by the Self-rating Anxiety Scale and Self-rating Depression Scale.Patients’emotions,stress perception and psychological resilience were evaluated by the Positive and Negative Affect Schedule,the Chinese Perceived Stress Scale,and the Connor-Davidson Resilience Scale(CD-RISC),respectively.Patient survival was calculated using the Kaplan-Meier method,and survival curves were plotted for analysis with the log-rank test.Univariate and multivariate survival analyses were performed using the Cox regression model.RESULTS The 33 OBC patients included 32 females and 1 male.Of the 33 patients,30(91%)had axillary tumors,3(9%)had a neck mass as the primary symptom;18(54.5%)had estrogen receptor-positive tumors,17(51.5%)had progesterone receptor-positive tumors,and 18(54.5%)had Her-2-positive tumors;24(72.7%)received surgical treatment,including 18 patients who underwent modified radical mastectomy,1 patient who underwent breast-conserving surgery plus axillary lymph node dissection(ALND),and 5 patients who underwent ALND alone;12 patients received preoperative neoadjuvant therapy.All 30 patients developed anxiety and depression,with low positive affect scores and high negative affect scores,accompanied by a high stress level and poor psychological resilience.There were no differences i
基金grants from the Na-tional Natural Science Foundation of China，Science and Technology Agency of Liaoning Province
文摘Objective: To compare the efficacy of axillary radiotherapy (ART) with that of completion axillary lymph node dissection (cALND) in clinically node-negative breast cancer patients with a positive sentinel lymph node. Methods: A literature search was performed in PubMed, EMBASE and Cochrane Library by using the search terms 'breast cancer', 'sentinel lymph node biopsy', 'axillary radiotherapy' or 'regional node irradiation' for articles published between 2004 and 2016. Only randomized controlled trials that included patients with positive sentinel nodes were included in the meta-analysis. Results: Two randomized controlled trials and three retrospective studies were identified. The reported overall survival rate (hazard ratio [HR] = 1.09, 95% confidence interval [CI]: 0.75-1.43, P = 0.365), disease-free survival rate (HR = 1.01, 95% CI:0.58-1.45, P = 0.144), and axillary recurrence rate (1.2% and 0.4%, and 1.3% and 0.8%, respectively) were similar in both groups. The absence of knowledge on the extent of nodal involvement in the ART group appeared to have no major impact on the administration of adjuvant systemic therapy. Conclusions: ART is not inferior to cALND in the patients with clinically node-negative breast cancer who had a positive sentinel lymph node. Information obtained by using cALND after SLNB may have no major impact on the administration of adjuvant systemic therapy.
文摘目的：探讨在乳腺癌腋窝淋巴结清扫术中超声刀和普通电刀对乳腺癌术后并发症的影响。方法回顾性分析92例乳腺癌腋窝淋巴结清扫术患者的临床资料，患者随机选择手术方式，其中采用超声刀37例，普通电刀55例，比较两组患者淋巴结检出数、手术时间、术后24 h 引流量、血清肿发生率和腋窝引流管留置时间。结果超声刀组手术时间为（148．2±30．4）min、检出淋巴结17个，腋窝引流管留置时间为（16．0±5．3）d，普通电刀组分别为（143．5±40．8）min，16个和（16．7±4．4），两组比较差异无统计学意义（P ＞0．05），超声刀组术后24 h 引流量为（118．8±65．8）ml，血清肿发生率为8．1％；普通电刀组分别为（159．2±71．3）ml 和20％，两组比较差异有统计学意义（P ＜0．01）。结论在乳腺癌腋窝淋巴结清扫术中超声刀和普通电刀对腋窝淋巴结清扫效果比较无明显差异，但采用超声刀后患者术后并发症明显减少。
基金Supported by Grants from the Breast Cancer Hope Foundation(London,United Kingdom)
文摘The sentinel lymph node biopsy(SLNB) was initially pioneered for staging melanoma in 1994 and it has been subsequently validated by several trials, and has become the new standard of care for patients with clinically node negative invasive breast cancer. The focussed examination of fewer lymph nodes in addition to improvements in histopathological and molecular analysis has increased the rate at which micrometastases and isolated tumour cells are identified. In this article we review the literature regarding the optimal management of the axilla when the SLNB is positive for metastatic disease based on level 1 evidence derived from randomised clinical trials.
文摘目的研究保留上肢淋巴结的乳腺癌腋窝淋巴结清扫术对预防上肢淋巴水肿的影响。方法方便选择2014年1月—2015年6月期间该院收治的T1~3 No Mo期70例乳腺癌患者,依照数字法随机分成观察组（35例）和对照组（35例）。分别为术前以纳米炭混悬液行经上臂逆行腋窝淋巴结示踪术组（观察组）和行经典腋窝淋巴结清扫术的对照组,比较两组疗效和预后。结果观察组术后1、4周及6个月患侧比健侧上肢臂围增加的百分比为（1.8±0.8）%、（1.8±0.7）%、（1.0±0.3）%,较对照组的（4.7±1.2）%、（4.5±1.1）%、（3.0±0.8）%减少更加明显（P〈0.05）。观察组术后预防上肢淋巴水肿的效果的优良率为97.14%（34/35）,明显高于对照组的71.43%（25/35）（P〈0.05）。观察组对于上肢淋巴水肿预防情况评分由（63.2±11.4）分改善至（87.3±10.3）分,明显高于对照组（P〈0.05）,差异均有统计学意义。结论保留上肢淋巴结的乳腺癌腋窝淋巴结清扫术对预防上肢淋巴水肿效果较好,值得推荐。
文摘The intercostobrachial nerve (ICBN) is responsible for the sensory</span></span></span></span></span><span><span><span><span><span><span style="font-family:""><span style="font-family:Verdana;"> innervation of a part of the inner side of the arm. Injury of the intercostobrachial nerve is </span><span style="font-family:Verdana;">a complication of axillary dissection during lymph node dissection.</span> <b><span style="font-family:Verdana;">Objective</span></b><span style="font-family:Verdana;">: </span><span style="font-family:Verdana;">This study aimed to determine the effect of preservation of the</span><span style="font-family:Verdana;"> intercostobra</span><span><span style="font-family:Verdana;">chial nerve on postoperative sensory disturbances. </span><b><span style="font-family:Verdana;">Methods:</span></b><span style="font-family:Verdana;"> This is a</span></span><span style="font-family:Verdana;"> prospective, single-center study which was carried out in 90 patients followed in the oncology department of the Aristide Le Dantec hospital in Dakar, suffering </span><span style="font-family:Verdana;">from breast cancer and having undergone breast surgery associated with</span><span style="font-family:Verdana;"> axillary </span><span style="font-family:Verdana;">dissection, for a period of 6 months. The patients were divided into two</span><span style="font-family:Verdana;"> groups depending on whether the intercostobrachial nerve (ICBN) was preserved or </span><span style="font-family:Verdana;">not. The two groups were compared in terms of the incidence of sensory</span><span style="font-family:Verdana;"> disturbances. </span><b><span style="font-family:Verdana;">Results:</span></b><span style="font-family:Verdana;"> Sixty patients without nerve preservation and 30 patients with nerve preservation were included in the study, </span><i><span style="font-family:Verdana;">i.e.</span></i><span style="font-family:Verdana;">, 90 patients in total. </span><span style="font-family:Verdana;">ICBN was injured in 60 pa
